Optimizing Adjuvant Endocrine Therapy: Where Do We Stand in 2008?
Grand Hyatt Kauai
Koloa, HI
July 23, 2008
|   | |
| 12:45 pm | Registration and Lunch |
| 1:00 pm | Welcome and Introductions Presession Survey Nancy Davidson |
| 1:05 pm | Case Discussion: Aromatase Inhibitors: Evidence for Up-Front, Switching, and Late-Extended Strategies and the Optimization of Treatment Duration Nancy Davidson |
| 1:25 pm | Case Discussion: The Role of Pharmacogenetics in Adjuvant Endocrine Therapy: Should Variables That Affect Tamoxifen Metabolism Alter Treatment Decisions? Eric P. Winer |
| 1:45 pm | Panel Discussion: Extended and Late-Extended Adjuvant Endocrine Therapy: Are the Current Standards for Endocrine Therapy Duration and Scheduling Sufficient? Nancy Davidson, Eric P. Winer |
| 1:55 pm | Postsession Survey |
| 2:00 pm | Adjourn |
An educational grant for this activity was provided by: